#VisualAbstract: Efficacy and safety of therapeutic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized...

In a group of hospitalized COVID-19 patients, a therapeutic dose of low-molecular-weight heparin reduced major thromboembolic events and death. Evidence Rating Level: 1 (Excellent) Thrombotic events...

#VisualAbstract: Increasing the number of SARS-CoV-2 immune family members associated with decreasing risk of...

Individuals not immune to COVID-19 had at least a 45% decreased risk of COVID-19 infection if at least one family member was...

#VisualAbstract: Methylprednisolone in severe COVID-19 pneumonia associated with clinical benefit in those with high...

Methylprednisolone therapy in nonintubated patients with COVID-19 receiving high-flow oxygen therapy was associated with clinical benefit solely in patients with baseline serum...

#VisualAbstract: Pembrolizumab after nephrectomy improves survival in renal-cell carcinoma patients

Patients receiving adjuvant pembrolizumab after nephrectomy for renal-cell carcinoma showed significantly improved disease-free survival compared to patients receiving placebo treatment. Patients...

All-time hits